Literature DB >> 25524504

Safety and diagnostic accuracy of tumor biopsies in children with cancer.

Rodrigo B Interiano1, Amos H P Loh, Nathan Hinkle, Fazal N Wahid, Alpin D Malkan, Armita Bahrami, Jesse J Jenkins, Shenghua Mao, Jianrong Wu, Kimberly Proctor, Victor M Santana, Alberto S Pappo, Robert E Gold, Andrew M Davidoff.   

Abstract

BACKGROUND: Tumor biopsies are central to the diagnosis and management of cancer and are critical to efforts in personalized medicine and targeted therapeutics. In the current study, the authors sought to evaluate the safety and accuracy of biopsies in children with cancer.
METHODS: All biopsies performed in children at the study institution with a suspected or established diagnosis of cancer from 2003 through 2012 were reviewed retrospectively. Patient characteristics and disease-related and procedure-related factors were correlated with procedure-related complications and diagnostic accuracy using logistic regression analysis.
RESULTS: A total of 1073 biopsies were performed in 808 patients. Of 1025 biopsies with adequate follow-up, 79 (7.7%) were associated with an adverse event, 35 (3.4%) of which were minor (grade 1-2) and 32 (3.1%) of which were major (grade 3-4) (grading was performed according to the National Cancer Institute Common Terminology Criteria for Adverse Events [version 4.0]). The most common major adverse events were blood transfusion (>10 mL/kg; 24 cases) and infection requiring intravenous antibiotics (6 cases). Eleven deaths (1.4%) occurred within 30 days after the procedure, but the procedure may have contributed to the outcome in only 2 cases. A total of 926 biopsies (90.3%) provided definitive histologic diagnoses. Using multivariable analysis, biopsy site, preprocedure hematocrit level, and body mass index were found to be associated with the risk of postprocedural complications (P<.0001, P<.0001, and P =.0029, respectively). Excisional biopsy and biopsy site were found to be independently associated with obtaining a diagnostic result (P =.0002 and P =.0008, respectively).
CONCLUSIONS: Tumor biopsies in children with cancer are associated with a low incidence of complications and a high rate of diagnostic accuracy. The predictive factors identified for adverse outcomes may aid in risk assessment and preprocedural counseling.
© 2014 American Cancer Society.

Entities:  

Keywords:  accuracy; biopsy; pediatrics; safety; tumors

Mesh:

Year:  2014        PMID: 25524504      PMCID: PMC4368446          DOI: 10.1002/cncr.29167

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  46 in total

1.  The Pediatric Cancer Genome Project.

Authors:  James R Downing; Richard K Wilson; Jinghui Zhang; Elaine R Mardis; Ching-Hon Pui; Li Ding; Timothy J Ley; William E Evans
Journal:  Nat Genet       Date:  2012-05-29       Impact factor: 38.330

2.  Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents.

Authors:  Mark Agulnik; Amit M Oza; Gregory R Pond; Lillian L Siu
Journal:  J Clin Oncol       Date:  2006-10-20       Impact factor: 44.544

3.  Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.

Authors:  Jane L Meza; James Anderson; Alberto S Pappo; William H Meyer
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

4.  Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases.

Authors:  Stephen S Koh; Jia-Perng J Wei; Xinmin Li; Rong R Huang; Ngan B Doan; Richard A Scolyer; Alistair J Cochran; Scott W Binder
Journal:  Mod Pathol       Date:  2012-03-09       Impact factor: 7.842

5.  The clonal and mutational evolution spectrum of primary triple-negative breast cancers.

Authors:  Sohrab P Shah; Andrew Roth; Rodrigo Goya; Arusha Oloumi; Gavin Ha; Yongjun Zhao; Gulisa Turashvili; Jiarui Ding; Kane Tse; Gholamreza Haffari; Ali Bashashati; Leah M Prentice; Jaswinder Khattra; Angela Burleigh; Damian Yap; Virginie Bernard; Andrew McPherson; Karey Shumansky; Anamaria Crisan; Ryan Giuliany; Alireza Heravi-Moussavi; Jamie Rosner; Daniel Lai; Inanc Birol; Richard Varhol; Angela Tam; Noreen Dhalla; Thomas Zeng; Kevin Ma; Simon K Chan; Malachi Griffith; Annie Moradian; S-W Grace Cheng; Gregg B Morin; Peter Watson; Karen Gelmon; Stephen Chia; Suet-Feung Chin; Christina Curtis; Oscar M Rueda; Paul D Pharoah; Sambasivarao Damaraju; John Mackey; Kelly Hoon; Timothy Harkins; Vasisht Tadigotla; Mahvash Sigaroudinia; Philippe Gascard; Thea Tlsty; Joseph F Costello; Irmtraud M Meyer; Connie J Eaves; Wyeth W Wasserman; Steven Jones; David Huntsman; Martin Hirst; Carlos Caldas; Marco A Marra; Samuel Aparicio
Journal:  Nature       Date:  2012-04-04       Impact factor: 49.962

Review 6.  Future of clinical genomics in pediatric oncology.

Authors:  Katherine A Janeway; Andrew E Place; Mark W Kieran; Marian H Harris
Journal:  J Clin Oncol       Date:  2013-04-15       Impact factor: 44.544

Review 7.  Pathological diagnosis of paediatric tumours from image-guided needle core biopsies: a systematic review.

Authors:  Neil J Sebire; Derek J Roebuck
Journal:  Pediatr Radiol       Date:  2006-03-11

8.  The evolution of treatment for Wilms tumor.

Authors:  Daniel M Green
Journal:  J Pediatr Surg       Date:  2013-01       Impact factor: 2.545

9.  Feasibility and safety of sequential research-related tumor core biopsies in clinical trials.

Authors:  Jung-min Lee; John L Hays; Anne M Noonan; Jennifer Squires; Lori Minasian; Christina Annunziata; Bradford J Wood; Minshu Yu; Katherine R Calvo; Nicole Houston; Nilofer Azad; Elise C Kohn
Journal:  Cancer       Date:  2012-12-20       Impact factor: 6.860

10.  Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia.

Authors:  Julia A Meyer; Jinhua Wang; Laura E Hogan; Jun J Yang; Smita Dandekar; Jay P Patel; Zuojian Tang; Paul Zumbo; Sheng Li; Jiri Zavadil; Ross L Levine; Timothy Cardozo; Stephen P Hunger; Elizabeth A Raetz; William E Evans; Debra J Morrison; Christopher E Mason; William L Carroll
Journal:  Nat Genet       Date:  2013-02-03       Impact factor: 38.330

View more
  3 in total

1.  Lymphadenopathy with coexisting normal architecture in malignant lymphoma.

Authors:  Shoji Saito; Yoshifumi Ogiso; Kazuo Sakashita
Journal:  Int J Hematol       Date:  2018-09-06       Impact factor: 2.490

2.  Initial diagnostic management of pediatric bone tumors.

Authors:  Rodrigo B Interiano; Alpin D Malkan; Amos H P Loh; Nathan Hinkle; Fazal N Wahid; Armita Bahrami; Shenghua Mao; Jianrong Wu; Michael W Bishop; Michael D Neel; Robert E Gold; Bhaskar N Rao; Andrew M Davidoff; Israel Fernandez-Pineda
Journal:  J Pediatr Surg       Date:  2016-03-02       Impact factor: 2.545

3.  The morbidity of open tumor biopsy for intraabdominal neoplasms in pediatric patients.

Authors:  Courtney L Devin; Erin A Teeple; Allison F Linden; Renee C Gresh; Loren Berman
Journal:  Pediatr Surg Int       Date:  2021-06-20       Impact factor: 1.827

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.